miR ‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma.
In conclusion, our findings indicate that miR‑486 may serve as a novel prognostic biomarker but may also be applied as a new therapeutic approach for the treatment of RCC.
PMID: 31661131 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Molecular Biology | Renal Cell Carcinoma | Study